NasdaqCM - Delayed Quote USD

Scinai Immunotherapeutics Ltd. (SCNI)

2.9100
+0.1500
+(5.43%)
At close: May 16 at 4:00:00 PM EDT
2.9900
+0.08
+(2.75%)
After hours: May 16 at 6:19:53 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
658
658
0
0
0
Cost of Revenue
1,238
1,238
0
0
--
Gross Profit
-580
-580
0
0
--
Operating Expense
8,058
8,058
9,706
11,061
10,862
Operating Income
-8,638
-8,638
-9,706
-11,061
-10,862
Net Non Operating Interest Income Expense
-1,332
-1,332
115
3,030
3,143
Other Income Expense
14,766
14,766
3,091
2,235
-487
Pretax Income
4,796
4,796
-6,500
-5,796
-8,206
Net Income Common Stockholders
0
0
-6,500
-5,796
-8,206
Diluted NI Available to Com Stockholders
0
0
-6,500
-5,796
-8,206
Basic EPS
0.00
--
-16.00
-40.00
-80.00
Diluted EPS
0.00
--
-16.00
-40.00
-80.00
Basic Average Shares
806.3680
--
390.6570
188.5190
141.1440
Diluted Average Shares
806.3680
--
390.6570
188.5190
141.1440
Total Operating Income as Reported
-8,638
-8,638
-9,706
-11,061
-10,862
Rent Expense Supplemental
--
--
--
--
101.0520
Total Expenses
9,296
9,296
9,706
11,061
10,862
Net Income from Continuing & Discontinued Operation
4,796
4,796
-6,500
-5,796
-8,206
Normalized Income
-6,573.8200
-6,573.8200
-9,591
-8,031
-7,719
Interest Income
100
100
3,924
3,051
3,152
Interest Expense
1,422
1,422
3,801
0
3,485.9734
Net Interest Income
-1,332
-1,332
115
3,030
3,143
EBIT
6,218
6,218
-2,699
-5,796
-10,862
EBITDA
7,867
7,867
-2,185
-5,234
-10,391
Reconciled Cost of Revenue
1,238
1,238
0
0
--
Reconciled Depreciation
1,649
1,649
514
562
471
Net Income from Continuing Operation Net Minority Interest
4,796
4,796
-6,500
-5,796
-8,206
Total Unusual Items Excluding Goodwill
14,766
14,766
3,091
2,235
-487
Total Unusual Items
14,766
14,766
3,091
2,235
-487
Normalized EBITDA
-6,899
-6,899
-5,276
-7,469
-9,904
Tax Rate for Calcs
0.0002
0.0002
0
0
0
Tax Effect of Unusual Items
3,396.1800
3,396.1800
0
0
0
12/31/2021 - 5/11/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ENLV.TA Enlivex Therapeutics Ltd.
353.70
-3.60%
 
ADXN Addex Therapeutics Ltd
8.50
+5.20%
 
DB0.F Q32 Bio Inc.
1.5300
+8.51%
 
ADXN.SW Addex Therapeutics Ltd
0.0554
-7.67%
 
SNPX Synaptogenix, Inc.
2.1600
-2.70%
 
DRMA Dermata Therapeutics, Inc.
0.7910
-0.38%
 
SONN Sonnet BioTherapeutics Holdings, Inc.
1.2900
+4.03%
 
INTS Intensity Therapeutics, Inc.
0.4200
-16.00%
 
ZIVO ZIVO Bioscience, Inc.
18.00
0.00%
 
ERNA Ernexa Therapeutics Inc.
0.2240
-4.27%